The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Different responses to dexamethasone and prednisolone in the same depressed patients
Abstract
Rationale Patients with major depression show hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, but the mechanisms underlying this abnormality are still unclear.Objectives We have compared two synthetic glucorticoids, dexamethasone and prednisolone, in their ability to suppress the hypothalamic-pituitary-adrenal (HPA) axis in depressed patients. Dexamethasone probes glucocorticoid receptor (GR) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.Materials and methods We used a single-blind, repeated-measure design. We administered placebo, prednisolone (5 mg) or dexamethasone (0.5 mg), at 22:00, to 18 severe, treatment-resistant depressed inpatients (15 of them with a history of childhood trauma) and 14 healthy volunteers. On the following days, we collected salivary cortisol from 9:00 to 22:00.Results Depressed patients had higher salivary cortisol levels compared with controls, at baseline and after both prednisolone and dexamethasone (p<0.001). Consistent with previous studies, depressed inpatients showed impaired suppression by dexamethasone: based on the analysis of the areas under the curve (AUCs), suppression by dexamethasone (0.5 mg) was -85% in controls vs -46% in depressed patients (p=0.018). However, the same depressed patients showed normal suppression by prednisolone (5 mg): suppression was -41% in controls and -36% in depressed patients (p=0.6).Conclusions We suggest that the additional effects of prednisolone on the MR explain the different responses to these glucocorticoids in the same depressed patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The plasma cortisol assay of the analyzer was suitably modified and then validated for these measurements. A set of 10 cortisol standards in saline were used in each assay to plot a calibration graph. This was highly reproducible with slope of (mean± SEM) 0.197 ± 0.004. The method correlated well with a previously published TR-FIA (Juruena et al., 2006). It had analytical sensitivity of 0.2 nmol/l”
From Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment (2010) · cites this paper as Juruena et al., 2006
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,374
Williams Textbook of Endocrinology
Melmed, S., & Polonsky, K. S. (2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,715
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Salivary cortisol in psychoneuroendocrine research: recent developments and applications
Kirschbaum, C., & Hellhammer, D. H. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90013-2 · Cited by 2,107
Heim, C. (2000) · JAMA · doi:10.1001/jama.284.5.592 · Cited by 1,968
Williams Textbook of Endocrinology
Stoffer, S. S. (1999) · JAMA · doi:10.1001/jama.281.9.851 · Cited by 1,245
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Self-citationDiagnostic and Statistical Manual of Mental Disorders
Preedy, V., & Watson, R. (2010) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5485 · Cited by 1,146
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886 · cited 2×
“Interestingly, dexamethasone and prednisolone are not metabolized by the same pathways (Czock et al. 2005).”
(2001) · PubMed · Cited by 780
The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana, G. W. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790350067012 · Cited by 526
Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420
Ladd, C. O., Huot, R. L., Thrivikraman, K. V., Nemeroff, C. B., & Plotsky, P. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.007 · Cited by 368
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
The DST as a predictor of outcome in depression: a meta-analysis
Ribeiro, S. C. M., Tandon, R., Grunhaus, L. J., & Greden, J. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1618 · Cited by 321
Loss of Glucocorticoid Fast Feedback in Depression
Young, E. A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320017003 · Cited by 299
Rupprecht, R., Reul, J. M. H. M., van Steensel, B., Spengler, D., Söder, M., Berning, B., Holsboer, F., & Damm, K. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90072-h · Cited by 297
Increased salivary cortisol after waking in depression
Bhagwagar, Z., Hafizi, S., & Cowen, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0062-z · Cited by 281
Heuser, I. J. E., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.-H., Dettling, M., Yassouridis, A., & Holsboer, F. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.93 · Cited by 275
The brain mineralocorticoid receptor: greedy for ligand, mysterious in function
Reul, J. M. H. M., Gesing, A., Droste, S. K., Stec, I. S. M., Weber, A., Bachmann, C. G., Bilang‐Bleuel, A., Holsboer, F., & Linthorst, A. C. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00677-4 · Cited by 230
Crochemore, C., Lu, J., Wu, Y., Liposits, Z., Sousa, N., Holsboer, F., & Almeida, O. F. X. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001679 · Cited by 216
Mineralocorticoid Receptor Function in Major Depression
Young, E. A., Lopez, J. F., Murphy-Weinberg, V., Watson, S. J., & Akil, H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.24 · Cited by 204
Do antidepressants regulate how cortisol affects the brain?
Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.009 · Cited by 194
Self-citationThe glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192
Self-citationEnhanced early morning salivary cortisol in neuroticism.
Portella, M., Harmer, C., Flint, J., Cowen, P., & Goodwin, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.807 · Cited by 178
Berne, C., GUNNARSSON, R., Hellerström, C., & Wilander, E. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92474-x · Cited by 175
Corticosteroid–serotonin interactions in depression: a review of the human evidence
Porter, R. J., Gallagher, P., Watson, S., & Young, A. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1774-1 · Cited by 169
Increase in Concentration of Waking Salivary Cortisol in Recovered Patients With Depression
Bhagwagar, Z., Hafizi, S., & Cowen, P. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1890 · Cited by 161
Pariante, C. M., Makoff, A., Lovestone, S., Feroli, S., Heyden, A., Miller, A. H., & Kerwin, R. W. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704368 · Cited by 159
Self-citationCortisol, serotonin and depression: All stressed out?
Cowen, P. J. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.99 · Cited by 157
Childhood Experience of Care and Abuse Questionnaire (CECA.Q)
Smith, N., Lam, D., Bifulco, A. T., & Checkley, S. (2002) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-002-0589-9 · Cited by 156
Glucocorticoid Receptor Function In Vitro in Patients with Major Depression
Pariante, C. M. (2004) · Stress · doi:10.1080/10253890500069650 · Cited by 147
Self-citationKunzel, H. E., Binder, E. B., Nickel, T., Ising, M., Fuchs, B., Majer, M., Pfennig, A., Ernst, G., Kern, N., Schmid, D. A., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300280 · Cited by 143
Ballard, P. L., CARTER, J. P., GRAHAM, B. S., & Baxter, J. D. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-2-290 · Cited by 135
Neuroendocrine Aspects of PTSD
Yehuda, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_13 · Cited by 117
Müller‐Vahl, K., Prevedel, H., Theloe, K., KOLBE, H., Emrich, H. M., & Schneider, U. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300047 · Cited by 111
The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone
Karssen, A. M., Meijer, O. C., van der Sandt, I. C. J., Boer, A. D., de Lange, E. C. M., & de Kloet, E. R. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750251 · Cited by 111
Nikisch, G., Mathé, A. A., Czernik, A., Thiele, J., Bohner, J., Eap, C. B., Ågren, H., & Baumann, P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0034-3 · Cited by 107
Lan, N. C., GRAHAM, B. S., Bartter, F. C., & Baxter, J. D. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-332 · Cited by 103
Altered glucocorticoid immunoregulation in treatment resistant depression
Bauer, M. E., Papadopoulos, A. S., Poon, L., Perks, P., Lightman, S. L., Checkley, S. A., & Shanks, N. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00009-4 · Cited by 91
Self-citationXing, G.-Q., Russell, S., Webster, M. J., & Post, R. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703004000 · Cited by 91
Pariante, C. M., Kim, R. B., Makoff, A., & Kerwin, R. W. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705357 · Cited by 89
Self-citationMüller, M. B., Keck, M. E., Binder, E. B., Kresse, A. E., Hagemeyer, T. P., Landgraf, R., Holsboer, F., & Uhr, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300257 · Cited by 88
Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine
Inder, W. J., Prickett, T. C. R., Joyce, P. R., Mulder, R., & Donald, R. A. (2001) · Psychopharmacology · doi:10.1007/s002130100737 · Cited by 79
A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis
Pariante, C. M., Papadopoulos, A. S., Poon, L., Checkley, S. A., English, J., Kerwin, R. W., & Lightman, S. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01314-2 · Cited by 74
Self-citationPariante, C. M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., & Kerwin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300195 · Cited by 70
Self-citationBjartmar, L., Johansson, I., Marcusson, J. O., Ross, S. B., Seckl, J. R., & Olsson, T. (2000) · Psychopharmacology · doi:10.1007/s002130000468 · Cited by 65
Bauer, M. E., Papadopoulos, A., Poon, L., Perks, P., Lightman, S. L., Checkley, S., & Shanks, N. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00243-3 · Cited by 62
Self-citationCorticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice
McAllister-Williams, H., Anderson, A. J., & Young, A. H. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002218 · Cited by 52
Pariante, C. M., Papadopoulos, A. S., Poon, L., Cleare, A. J., Checkley, S. A., English, J., Kerwin, R. W., & Lightman, S. L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1925-4 · Cited by 52
Self-citationAcute citalopram administration produces correlated increases in plasma and salivary cortisol
Bhagwagar, Z., Hafizi, S., & Cowen, P. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1149-4 · Cited by 51
Reynolds, R. M., Bendall, Whorwood, Wood, Walker, & Phillips (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00549.x · Cited by 43
Does the dexamethasone suppression test have clinical utility in psychiatry?
Baldessarini, R. J., & Arana, G. W. (1985) · PubMed · Cited by 41
CLINICAL AND METABOLIC EFFECTS OF DEXAMETHASONE
Slater, J. D. (1959) · The Lancet · doi:10.1016/s0140-6736(59)90370-8 · Cited by 39
Contrasting effects of citalopram and reboxetine on waking salivary cortisol
Harmer, C. J., Bhagwagar, Z., Shelley, N. C., & Cowen, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1417-y · Cited by 38
Mineralocorticoid Receptor-Like Aldosterone-Binding Protein in Cell Culture*
Lan, N. C., Matulich, D. T., MORRIS, J. A., & Baxter, J. D. (1981) · Endocrinology · doi:10.1210/endo-109-6-1963 · Cited by 36
5-Hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone
Porter, R. J., McAllister-Williams, H., Lunn, B. S., & Young, A. H. (1998) · Psychopharmacology · doi:10.1007/s002130050711 · Cited by 32
Bschor, T., Baethge, C., Adli, M., Eichmann, U., Ising, M., Uhr, M., Müller-Oerlinghausen, B., & Bauer, M. (2003) · Depression and Anxiety · doi:10.1002/da.10078 · Cited by 27
The dexamethasone and cortisol suppression test in depression: β-endorphin as a useful marker
Wied, C. C. G., Westenberg, H. G. M., Thijssen, J. H. H., & van Ree, J. M. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90064-3 · Cited by 25
The impact of dexamethasone pharmacokinetics on the DST: a review.
Guthrie, S. (1991) · PubMed · Cited by 24
Post, A., Ohl, F., Almeida, O. F. X., Binder, E. B., Rücker, M., Welt, S., Binder, E., Holsboer, F., & Sillaber, I. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2134-x · Cited by 20
Studies of structure-function relationships of steroids. II. The 6 alpha-methylcorticosteroids.
Liddle, G. W. (1958) · PubMed · Cited by 19
Acute Reboxetine Administration Increases Plasma and Salivary Cortisol
Hill, S. A., Taylor, M. J., Harmer, C. J., & Cowen, P. J. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173008 · Cited by 17
Wied, C. C. G., Jansen, L. M. C., Wynne, H. J. A., Matthys, W., van der Gaag, R. J., Thijssen, J. H. H., & van Engeland, H. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00097-8 · Cited by 17
Vasoconstrictor response to topical beclomethasone in major depression
Cotter, P. A., Mulligan, O. F., Landau, S., Papadopoulos, A. S., Lightman, S. L., & Checkley, S. A. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00065-8 · Cited by 15
Self-citationEffects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion
Porter, R., McAllister-Williams, H., Jones, S., & Young, A. H. (1999) · Psychopharmacology · doi:10.1007/s002130050920 · Cited by 14
Effects of adrenalectomy on 8-OH-DPAT induced hypothermia in mice
McAllister-Williams, H., Man, M., & Young, A. H. (1999) · Psychopharmacology · doi:10.1007/s002130050864 · Cited by 13
Cooney, J. M., & Dinan, T. G. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00549-8 · Cited by 13
Wied, C. C. G., D’Haenen, H., Verhoeven, W. M. A., Wynne, H. J. A., Westenberg, H. G. M., Thijssen, J. H. H., & van Ree, J. M. (1993) · Psychoneuroendocrinology · doi:10.1016/0306-4530(93)90004-5 · Cited by 13
Preservation of hypothalamic‐pituitary‐adrenal axis fast‐feedback responses in depression
Cooney, J. M., & Dinan, T. G. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09889.x · Cited by 8
Ritzi, E. M. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00241-3 · Cited by 3
Cited by
Sorted by citations
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Self-citationCarr, C. P., Martins, C. M. S., Stingel, A. M., Lemgruber, V. B., & Juruena, M. F. (2013) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000049 · Cited by 802
Self-citationKim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
Self-citationGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Self-citation
Metadata
- Authors
- Juruena, M. F., Cleare, A. J., Papadopoulos, A. S., Poon, L., Lightman, S., & Pariante, C. M.
- Affiliations
- King's College London (GB)
- Bethlem Royal Hospital (GB)
- University of Bristol (GB)
- Corresponding author
- Pariante, Carmine M.
- Venue
- Psychopharmacology
- Published
- 2006-10-03
- Volume
- 189
- Issue
- 2
- Pages
- 225-235
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2080795205
- Cited by
- 147
- References
- 75
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 4 · 2017: 12 · 2016: 3 · 2015: 10 · 2014: 8 · 2013: 11 · 2012: 7
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- major depressive disorder, dexamethasone suppression test, hypothalamic-pituitary-adrenal axis, HPA axis hyperactivity, glucocorticoid receptor, mineralocorticoid receptor, salivary cortisol, treatment-resistant depression, childhood trauma
- MeSH terms
- Major Depressive Disorder, Dexamethasone, Female, Glucocorticoids, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Prednisolone, Receptors, Glucocorticoid, Saliva, Salivary Glands, Single-Blind Method, Receptors, Mineralocorticoid, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review